Behfar Ehdaie
@BehfarEhdaieMD
Associate Professor Surgery @MSKCancerCenter | BA @UVA | MD @Georgetown | MPH @Harvard | Husband | Father | Mentor *Opinions expressed are my own*
💥On behalf of co-investigators @claretempany @adamkibel_uro @qdtrinh and co-senior authors @geoffsonn Peji Ghanouni, we are excited to share the FINAL results of MR-guided HIFU Focal Therapy in men with intermediate risk prostate cancer. 1/8 thelancet.com/journals/lanon…
Come join us for hopefully an engaging and balanced AUA Course reviewing key concepts in prostate cancer focal therapy. Distinguished faculty discuss their experience and reveal advanced techniques using all focal therapy technology in a lively case-based format #AUA25

The inaugural Masterclass in Robotic HIFU for Prostate Cancer is only one day away! We are excited to have focal therapy experts Pierre Halteh, MD, @AmirLebastchi, MD, @BehfarEhdaieMD and Pr. Sebastien Crouzet share their personal experience. @USC_Urology @FocalOneHIFU
Now in Clin Genitourin Cancer by @UrologyMSK @SigridCarlsson @vinlaudonemd @TouijerKarim @easthamja @BehfarEhdaieMD et al: Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Grade Group 2 Prostate Cancer on Active Surveillance sciencedirect.com/science/articl…
#GU Reporting Insights: #ProstateCancer Program Covers: 1) prework talks (now available online) and 2) live-streamed webinar on Jan 22, 2025. Please register and share! Big discounts for junior CAP members! #GUPath #Pathology 👇👇👇 education.cap.org/node/12787
Is it possible to conduct large randomized surgical clinical trials in a single institution? The answer is yes, say Andrew Vickers and colleagues, reporting their experiences at Memorial Sloan Kettering. @SCTorg @VickersBiostat @MSKCancerCenter @MSKBiostats @BehfarEhdaieMD
#SUO24 #Debate – Management of localized radiorecurrent #ProstateCancer: Salvage radical prostatectomy. Presentation by @BehfarEhdaieMD @MSKCancerCenter. Written coverage by @zklaassen_md @GACancerCenter > bit.ly/3VteScK @UroOnc
Come join us for hopefully an engaging and balanced AUA Course reviewing the role of focal therapy in prostate cancer & translating the outcomes of clinical trials in clinical practice. Agnostic of technology but esteemed faculty discussing experience with all FT devices. #AUA24

GUPS companion meeting at USCAP is almost here!
“Lu”tectomy using Lu-PSMA + Radical Prostatectomy is feasible and reports a signal for response in Phase I study. Novel work from @PeterMacCC @RenuEapen @declangmurphy #KPS2024



Wonderful invitation to exchange ideas at the International Prostate Cancer meeting in Seoul, Korea. PSA testing low in Korea due to low social perception of risk. However, risk of prostate cancer in Korea continues to rise!


4 Weeks from TODAY!! Join the @GU_Path_Society Companion Society Meeting #USCAP2024 featuring: Dr. Sean Williamson @Williamson_SR Dr. Francesca Khani @FKhaniPath Dr. Behfar Ehdaie @BehfarEhdaieMD Moderated by: @LotanLab @FionaMacPath #gupath #UroSoMe
What is the clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 #prostatecancer? #pcsm ow.ly/Z8nG30nadPK @rovingatuscap @easthamja @BehfarEhdaieMD
Congratulations to @UrologyMSK fellow Christopher Gaffney! Excited to watch your career takeoff. 👏
CONGRATULATIONS to the Class of 2023 @PCFnews Young Investigator Awardees!!! 🥳🥳🥳👏👏👏🎉🎉🎉 We are so proud to fund these early career physicians and scientists who are committed to advancing the #ProstateCancer field!! pcf.org/c/the-prostate…
Andrew Vickers and colleagues provide evidence that conducting informed consent in two stages can reduce patient anxiety. @VickersBiostats @BehfarEhdaieMD @SigridCarlsson @SCTorg #informedconsent @picphysicians #clinicaltrials @MSKBiostats @MSKCancerCenter
Thank you @AdityaBagrodia for producing an engaging and wonderful Podcast discussion with Dr Scardino; a mentor and role model to so many of us. A must listen! @uroegg
It was a pleasure to listen to @AdityaBagrodia ’s interview with Dr. Peter Scardino on the @_backtableUro podcast. Listen to learn leadership pearls from a legend! #UroSoMe @NYSAUA @bbmdmsk @touijerKarim @morr316 @BehfarEhdaieMD cms.megaphone.fm/channel/BTL216…
It was a pleasure to listen to @AdityaBagrodia ’s interview with Dr. Peter Scardino on the @_backtableUro podcast. Listen to learn leadership pearls from a legend! #UroSoMe @NYSAUA @bbmdmsk @touijerKarim @morr316 @BehfarEhdaieMD cms.megaphone.fm/channel/BTL216…
Important study led by @UrologyMSK fellows Chris Gaffney and @GhalibJibara. MRI imaging has increased the detection of higher grade cancers but we need to be careful to only use the highest grade from those cores to guide our decisions- a call for a new system. @rovingatuscap
Grade migration in prostate cancer? 🤔 Where grade is discordant between systematic and MRI-targeted biopsies, risk of adverse pathology and biochemical recurrence is intermediate between grades. Real implications for using the highest grade to determine risk groups and make…